MiNK Therapeutics (6Q40.F) Q4 2025 Earnings

14NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.91
-0.75
-0.6
-0.44

Details

Expected EPS
-0.7355565
Actual EPS
-0.559195
Surprise EPS
0.18
Surprise Percent
+23.98%

Description

MiNK Therapeutics (6Q40.F) has reported earnings of -0.559195 per share for Q4 2025.

0 Comments

Share your thoughts